Resistance to antibiotics: A challenge in chemotherapy

Indian Journal of Pharmaceutical Education and Research

Volumn 42, Issue 1, 2008, Pages 3-11

  Bari, S B ^a   Mahajan, B M ^a   Surana, S J ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antibiotic resistance; Mechanism of resistance; Mutation

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFTOBIPROLE; CHLORAMPHENICOL; CLINDAMYCIN; DALBAVANCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; ISEPAMICIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; MINOCYCLINE; ORITAVANCIN; PENICILLIN DERIVATIVE; PENICILLIN G; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RO 63914; STREPTOMYCIN; SULFONAMIDE; TELITHROMYCIN; TETRACYCLINE DERIVATIVE; TIGECYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL TRANSMISSION; CELL MEMBRANE PERMEABILITY; DRUG EFFICACY; DRUG HYDROLYSIS; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG TARGETING; GENE MUTATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN; PLASMID; TRANSPOSON;

EID: 77953376947     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Finch RG, Greenwood D, Norbby SR, Whitley RJ. Antibiotic and Chemotherapy: Antiinfective agents and their use in therapy. 8th ed. ChurchilLivingstone 2003.
2. FDA Consumer Magazine 1995;29(7).
3. What causes antibiotic resistance in bacteria? Available from b.leeds.ac.uk/mbiology/ug/ugtech/icu8/antibiotics/resistance/resnotes.htm
4. Bush Jacoby GA. A Functional classification scheme for beta-lactamase and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 1995;39:1211-33.
5. Medeiros AA. Evolution and dissemination of Beta-lactamase accelerated by generation of beta lactam antibiotics. Clinical Infectious diseases 1997;24:S19-S45.
6. Mingeot-Leclercq MP, Tulkens PM. aminoglycosides: activity and resistance. Antimicrobial Agents and Chemotherapy 1999;43:727-37.
7. Hakenbeck R, Kkaminski K, Konig A et al. Penicillin-binding proteins in beta-lactam-resistant Streptococcus pneumoniae. Microbial drug resistance 1999;5:91-9.
8. Roberts MC, Courvalin P et al. Nomenclature for macrolide and macrolide-Lincosamide Streptogramin B resistance determinants. Antimicrobial Agents and Chemotherapy 1999;43:2823-30.
9. Hugo WB, Russell AD. Pharmaceutical Microbiology. 6th ed. Blackwell Science Ltd. 181-200.
10. Davies J. Inactivation of antibiotics and dissemination of resistance gene. Science 1994;264:375-82.
11. Salyers AA, Amabilc-Cuevas CF. Why antibiotic resistance gene so resistant to elimination? Antimicrobial Agents and Chemotherapy 1997;41:2321-5.
12. Attack of the Superbugs: Antibiotic resistance. Available from http://www.biotech.ubc.ca/Biodiversity/AttackOfTheSuperbugs.htm
13. Opal SM, Mayer KH, Medeiros AA. Mechanisms of bacterial antibiotic resistance. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. 5th ed. Philadelphia, PA: Churchill Livingstone; 2000.
14. Hawkey PM. Mechanisms of resistance to antibiotics. Intensive Care Med 2000;26:S9-S13.
15. Kaye KS, Fraimow HS, Abrutyn E. Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am 2000;14:293-319.
16. Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature 2000;406: 775-81.
17. Grayson ML, Eliopoulos GM. Antimicrobial resistance in the intensive care unit. Semin Respir Infect 1990;5:204-14.
18. Michael TB, Hodgson J. Novel target sites in bacteria for overcoming antibiotic resistance. Adv. Drug Delivery Reviews 2005;57:1528-38.
19. Heath RJ, White SW, Rock CO. Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics Appl. Microbiol. Biotechnol 2002;58:695-703.
20. Payne DJ. The potential of bacterial fatty acid biosynthetic enzymes as a source of novel antibacterial agents. Drug News Perspect 2004;17:187-94.
21. Kim S, Lee SW, Choi EC, Choi SY. Aminoacyl-tRNA synthetases and their inhibitors as a novel family of antibiotics. Appl. Microbial. Biotechnol 2003;61:278-88.
22. Matsushita M, Janda KD. Histidine kinases as targets for new antimicrobial agents. Bioorg. Med. Chem 2002;10:855-67.
23. Alexeyev MF. The pKNOCK series of broad-hostrange mobilizable suicide vectors for gene knockout and targeted DNA insertion into the chromosome of Gram-negative bacteria. Biotechniques 1999;26:824-8.
24. Vagner V, Dervyn E, Ehrlich ED. A vector for systematic gene inactivation in Bacillus subtilis. Microbiology 1998;144:3097-104.
25. Lacks SA. Cloning and expression of pneumococcal genes in Streptococcus pneumoniae. Microb. Drug Resist 1997;3:327-37.
26. Cregg KM, Wilding I, Black MT. Molecular cloning and expression of the spsB gene encoding an essential type I signal peptidase from Staphylococcus aureus J. Bacteriol 1996;178: 5712-8.
27. De Souza JA, Blackstock W, Di Modugno V et al. Two-component systems in Haemophilus influenzae: a regulatory role for ArcA in serum resistance. Infect. Immun 2003;71:163-72.
28. Akerley BJ, Rubin EJ, Camilli A et al. Systematic identification of essential genes by in vitro mariner mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 1998;95:8927-32.
29. Camilli A, Beattie DT, Mekalanos JJ. Use of genetic recombination as a reporter of gene expression. Proc. Natl. Acad. Sci. U. S. A. 1994;91: 2634-8.
30. Hensel M, Holden DW. Signature-tagged mutagenesis. Molecular genetic approaches for the study of virulence in both pathogenic bacteria and fungi. Microbiology 1996;194:1049-58.
31. Annis DA, Nazef N, Chuang CC, Scott MP, Nash HM. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures. J. Am. Chem. Soc 2004;126:15495-15503.
32. Doman DM, McGovern SM et al. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J. Med. Chem 2002;45:2213-21.
33. Appelbaum PC, Jacobs MR. Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria. Current Opinion in Microbiology 2005; 8:510-7.
34. US Integracy Task Force on antimicrobial drug resistance 2001 Public health action plan to combat antimicrobial drug resistance. Available from http://www.cdc.gov/drugresistance/actionplan/index.htm
35. Who 2001 global strategy for containment of antimicrobial resistance Geneva. Available from http://www.who.int/ems/amr.htm.